 |
She is Professor of Translational Vascular Neuroscience at the University of Edinburgh, UK. She earned her PhD in Clinical Neuroscience at Utrecht University Medical Centre, Netherlands, followed by postdoctoral training at Massachusetts General Hospital and Harvard Medical School in Boston. There, she founded the Translational CAA Research Lab to study microvascular brain injury in cerebral amyloid angiopathy (CAA), linked to haemorrhagic stroke and cognitive decline. The lab uses in vivo MRI, ex vivo histopathology, and two-photon microscopy to identify treatment targets. In summer 2025, it relocated to the UK’s BHF-UK DRI Centre for Vascular Dementia Research. |
